The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2016

Filed:

Nov. 12, 2010
Applicants:

Takehiro Takahashi, Kamakura, JP;

Hiroki Kumagai, Kamakura, JP;

Takashi Kadowaki, Tokyo, JP;

Naoto Kubota, Tokyo, JP;

Tetsuya Kubota, Tokyo, JP;

Inventors:

Takehiro Takahashi, Kamakura, JP;

Hiroki Kumagai, Kamakura, JP;

Takashi Kadowaki, Tokyo, JP;

Naoto Kubota, Tokyo, JP;

Tetsuya Kubota, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/5585 (2006.01); A61P 31/10 (2006.01); A61K 31/343 (2006.01); A61K 31/4439 (2006.01); A61K 31/5575 (2006.01);
U.S. Cl.
CPC ...
A61K 31/343 (2013.01); A61K 31/4439 (2013.01); A61K 31/5575 (2013.01);
Abstract

A therapeutic or prophylactic agent for diabetes includes a thiazolidine derivative as a PPAR-γ agonist as an effective component which exhibits a reduced side effect of the PPAR-γ agonist. The therapeutic or prophylactic agent for diabetes includes a particular IP agonist such as beraprost sodium (BPS), and a thiazolidine derivative such as pioglitazone or a pharmaceutically acceptable salt thereof. Since the therapeutic or prophylactic agent exhibits a sufficiently effective hypoglycemic action without being accompanied by side effects characteristic to PPAR-γ agonists, the agent is useful as a highly safe and effective therapeutic or prophylactic agent for diabetes.


Find Patent Forward Citations

Loading…